Recent studies have shown ectopic expression of such embryonic antigens as SSEA-3, SSEA-4, Oct-4, and Nanog, in cancer cells [5–7] highlighting the potential of embryonic-derived antigens to be employed in cancer vaccines [8, 9]. This evidence concerns the gene POU5F1 and cancer.